Programación del desfibrilador automático implantable

Revista Española de Cardiología Suplementos - Tập 8 - Trang 65A-75A - 2008
José M. Ormaetxe-Merodio1, Jesús D. Martínez-Alday1, María F. Arcocha-Torres1, Rubén García-Martín1
1Laboratorio de Electrofisiología. Servicio de Cardiología. Hospital de Basurto. Bilbao. España

Tài liệu tham khảo

Mirowski, 1980, Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings, N Engl J Med, 303, 322, 10.1056/NEJM198008073030607 Wietholdt, 1993, Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter defibrillator, J Am Coll Cardiol, 21, 885, 10.1016/0735-1097(93)90343-Y Higgins, 1995, Stability: an ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia, J Cardiovasc Electrophysiol, 6, 1081, 10.1111/j.1540-8167.1995.tb00385.x Neuzner, 1995, Programmable VT detection enhancements in implantable cardioverter defibrillator therapy, PACE, 18, 539, 10.1111/j.1540-8159.1995.tb02564.x Brugada, 1998, Enhanced detection criteria in implantable defibrillators, J Cardiovasc Electrophysiol, 6, 261, 10.1111/j.1540-8167.1998.tb00911.x Schaumann, 1996, Enhanced detection criteria in implantable cardioverter defibrillators to avoid inappropriate therapies, Am J Cardiol, 78, A42, 10.1016/S0002-9149(96)00501-2 Brugada, 1999, Is inappropriate therapy a resolved issue with implantable cardioverter defibrillators?, Am J Cardiol, 83, D40, 10.1016/S0002-9149(98)00967-9 Weber, 1999, Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators, J Cardiovasc Electrophysiol, 10, 145, 10.1111/j.1540-8167.1999.tb00655.x Swerdlow, 1994, Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy, J Am Coll Cardiol, 23, 1342, 10.1016/0735-1097(94)90376-X Swerdlow, 1994, Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator, J Am Coll Cardiol, 24, 416, 10.1016/0735-1097(94)90298-4 Duru, 2000, Morphology discriminator feature for enhanced ventricular tachycardia discrimination in implantable cardioverter defibrillators, PACE, 23, 1365, 10.1111/j.1540-8159.2000.tb00964.x Boriani, 2001, Clinical evaluation of Morphology Discrimination, an algorithm for rhythm discrimination in cardioverter-defibrillators, PACE, 24, 994, 10.1046/j.1460-9592.2001.00994.x Korte, 2000, Neues ICD-morphologie-kriterium zur differenzierung supraventrikularer und ventrikularer tachycardien, Z Kardiol, 89, 1019, 10.1007/s003920070154 Dijkman, 2000, Dual chamber arrhythmia detection in the implantable cardioverter defibrillator, J Cardiovasc Electrophysiol, 11, 1105, 10.1111/j.1540-8167.2000.tb01756.x Kuhlkamp, 1999, Clinical experience with the new detection algorithm for atrial fibrillation of a defibrillator with dual chamber sensing and pacing, J Cardiovasc Electrophysiol, 10, 905, 10.1111/j.1540-8167.1999.tb01261.x Deisenhofer, 2001, Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study, J Cardiovasc Electrophysiol, 12, 134, 10.1046/j.1540-8167.2001.00134.x Friedman, 2006, Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis. The Detect Supraventricular Tachycardia Study, Circulation, 113, 2871, 10.1161/CIRCULATIONAHA.105.594531 Quesada, 2004, The DATAS rationale and design: a controlled, randomized trial to asses the clinical Benedit of dual chamber (DDED) defibrillator, Europace, 6, 142, 10.1016/j.eupc.2003.11.011 Almendral, 2006, The DATAS trial: Clinically Significant Adverse Events in Single vs Dual Chamber ICD, Circulation, 114, II397 Winkle, 1989, Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform, Am Heart J, 117, 122, 10.1016/0002-8703(89)90665-0 Bardy, 1989, A prospective, randomized evaluation of biphasic vs. monophasic waveform pulses on defibrillation efficacy in humans, J Am Coll Cardiol, 14, 728, 10.1016/0735-1097(89)90118-6 Block, 1995, Optimizing defibrillation through improved waveforms, PACE, 18, 526, 10.1111/j.1540-8159.1995.tb02563.x Jackman, 1982, Low energy synchronous cardioversion of ventricular tachycardia using a catheter electrode in a canine model of subacute myocardial infarction, Circulation, 66, 187, 10.1161/01.CIR.66.1.187 Zipes, 1982, Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode, Am Heart J, 103, 789, 10.1016/0002-8703(82)90390-8 Bardy, 1993, A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion, Circulation, 87, 1889, 10.1161/01.CIR.87.6.1889 Bucknall, 1987, Transvenous cardioversion for the management of recurrent ventricular arrhythmias, Br Heart J, 58, 245, 10.1136/hrt.58.3.245 Winkle, 1984, Measurement of cardioversion defibrillation thresholds in man by a truncated exponential waveform and an apical match-superior vena caval spring electrode configuration, Circulation, 69, 766, 10.1161/01.CIR.69.4.766 Ciccone, 1985, A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia, Circulation, 71, 571, 10.1161/01.CIR.71.3.571 McVeigh, 1991, Clinical efficacy of low energy cardioversion in automatic implantable cardioverter-defibrillator patients, PACE, 14, 1846, 10.1111/j.1540-8159.1991.tb02777.x Lauer, 1994, Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease, Am J Cardiol, 73, 559, 10.1016/0002-9149(94)90333-6 Miles, 1986, The implantable transvenous cardioverter: long-term efficacy and reproducible induction of ventricular tachycardia, Circulation, 74, 518, 10.1161/01.CIR.74.3.518 Jung, 1992, Incidence of atrial fibrillation following shock delivery of an implantable defibrillator: comparison of two lead systems, PACE, 16, 567 Saksena, 1985, Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: a prospective, randomized, crossover study, Circulation, 72, 153, 10.1161/01.CIR.72.1.153 Fisher, 1978, Termination of ventricular tachycardia with bursts of rapid ventricular pacing, Am J Cardiol, 41, 94, 10.1016/0002-9149(78)90138-8 Luderitz, 1994, Antitachycardia pacing, 271 Gross, 1993, The antitachycardia pacing ICD: impact on patients selection and outcome, PACE, 16, 165, 10.1111/j.1540-8159.1993.tb01555.x Rosenqvist, 1995, Pacing techniques to terminate ventricular tachycardia, PACE, 18, 592, 10.1111/j.1540-8159.1995.tb02569.x Charos, 1986, A theoretically and practically more effective method for interruption of ventricular tachycardia: self-adapting autodecremental overdrive pacing, Circulation, 73, 309, 10.1161/01.CIR.73.2.309 Gillis, 1993, A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease, Am J Cardiol, 72, 1146, 10.1016/0002-9149(93)90984-K Calkins, 1993, Comparison of fixed burst versus decremental burst pacing for termination of ventricular tachycardia, PACE, 16, 26, 10.1111/j.1540-8159.1993.tb01531.x Kantoch, 1993, Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia, PACE, 16, 1664, 10.1111/j.1540-8159.1993.tb01037.x Newman, 1993, Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia, J Am Coll Cardiol, 21, 1413, 10.1016/0735-1097(93)90318-U Hammill, 1995, Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group, PACE, 18, 3, 10.1111/j.1540-8159.1995.tb02469.x Cook, 1992, Comparison of decremental and burst overdrive pacing as treatment for ventricular tachycardia associated with coronary artery disease, Am J Cardiol, 70, 311, 10.1016/0002-9149(92)90610-B Schaumann, 1998, Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients, Circulation, 97, 66, 10.1161/01.CIR.97.1.66 Nasir, 1997, Spontaneous ventricular tachycardia treated by antitachycardia pacing. Cadence Investigators, Am J Cardiol, 79, 820, 10.1016/S0002-9149(96)00881-8 Peinado, 1998, Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia, Am J Cardiol, 82, 1422, 10.1016/S0002-9149(98)00654-7 Mont, 1999, Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation, J Am Coll Cardiol, 34, 351, 10.1016/S0735-1097(99)00206-5 Wathen, 2001, Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease, Circulation, 104, 796, 10.1161/hc3101.093906 Wathen, 2004, Circulation, 110, 2591, 10.1161/01.CIR.0000145610.64014.E4 Jimenez Candil, 2005, Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: efficacy and safety of antitachycardia pacing. A prospective and randomized study, J Am Coll Cardiol, 450, 460, 10.1016/j.jacc.2004.11.008 Schaumann, 1998, Multiple attempts of antitachycardia pacing are useful in implantable cardioverter-defibrillators, J Am Coll Cardiol, 31, 434A, 10.1016/S0735-1097(97)85591-X Epstein, 1989, Combined automatic implantable cardioverter-defibrillator and pacemaker systems: implantation techniques and follow-up, J Am Coll Cardiol, 13, 121, 10.1016/0735-1097(89)90559-7 Calkins, 1990, Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators, J Am Coll Cardiol, 16, 666, 10.1016/0735-1097(90)90358-V Platia, 1986, Post-defibrillation bradycardia following implantable defibrillator discharge, J Am Coll Cardiol, 7, 73A Mitchell, 2002, Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation, J Am Coll Cardiol, 39, 1323, 10.1016/S0735-1097(02)01784-9 Yee, 1984, Changes in pacing threshold and R wave amplitude after transvenous catheter countershock, J Am Coll Cardiol, 4, 543, 10.1016/S0735-1097(84)80099-6 Slepian, 1987, Automatic implantable cardioverter defibrillator/permanent pacemaker interactions: loss of pacemaker capture following AICD discharge, PACE, 10, 1194, 10.1111/j.1540-8159.1987.tb06140.x Wilkoff, 2002, Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial, JAMA, 288, 3115, 10.1001/jama.288.24.3115 Sweeney, 2002, Baseline QRS duration > 120 msec and cumulative percent time ventricular paced predicts increased risk of heart failure, stroke and death in DDDR-paced patients with sick sinus syndrome in MOST (abstract), PACE, 336, 1845 Andersen, 1997, Long term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome, Lancet, 350, 1210, 10.1016/S0140-6736(97)03425-9 Kerr, 2004, Canadian trial of physiological pacing: effects of physiological pacing during long-term follow-up, Circulation, 109, 357, 10.1161/01.CIR.0000109490.72104.EE Sweeney, 2005, Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT Reduces Shock Therapies (PainFREE Rx II) trial, Circulation, 111, 2898, 10.1161/CIRCULATIONAHA.104.526673 Marin, 2006, Desfibrilador automatico en la miocardiopatia hipertrofica. Experiencia de 3 centros, Rev Esp Cardiol, 59, 537, 10.1157/13089740 Sacher, 2006, Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A multicenter study, Circulation, 114, 2317, 10.1161/CIRCULATIONAHA.106.628537